Unbound MEDLINE

Articles related to 10792471 journal articles from PubMed MEDLINE database

Unbound MEDLINE results for:Bookmark this site
Articles related to 10792471 [Unique ID], provided by the PubMed system
1 - 10 of 329 journal articles in the PubMed databaseEmail to a friend    
 
Powell JS, Bush M, Harrison J, et al. 
Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia A. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Haemophilia 2000 May; 6(3):140-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Mannucci PM, Chediak J, Hanna W, et al. 
Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. [Clinical Trial, Controlled Clinical Trial, Journal Article, Multicenter Study]
Blood 2002 Jan 15; 99(2):450-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Nemes L, Lissitchkov T, Klukowska A, et al. 
Evaluation of pharmacokinetics, efficacy and safety of Immunate((R)) solvent detergent in previously treated patients with severe haemophilia A. [Journal Article]
Haemophilia 2007 Jan; 13(1):9-11.
Abstract | Full Citation | Find Related Articles 
Ristol P, Gensana M, Fernández J, et al. 
[Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)] [Journal Article]
Sangre (Barc) 1996 Apr; 41(2):131-6.
Abstract | Full Citation | Find Related Articles 
Gringeri A, Monzini M, Tagariello G, et al. 
Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate. [Journal Article]
Haemophilia 2006 Mar; 12(2):128-32.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Saez A, Bosh N, Boadas N, et al. 
Pharmacokinetics and acute tolerance of a double virus inactivated plasma derived factor VIII concentrate. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Haemophilia 1999 Jul; 5(4):260-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Rothschild C, Scharrer I, Brackmann HH, et al. 
European data of a clinical trial with a sucrose formulated recombinant factor VIII in previously treated haemophilia A patients. [Clinical Trial, Journal Article, Multicenter Study]
Haemophilia 2002 Mar.:10-4.
Abstract | Full Citation | Find Related Articles 
Tarantino MD, Collins PW, Hay CR, et al. 
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Haemophilia 2004 Sep; 10(5):428-37.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Santagostino E, Mannucci PM, Gringeri A, et al. 
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. [Journal Article]
Transfusion 1997 May; 37(5):517-22.
Abstract | Full Citation | Find Related Articles 
New Search Next Results
  

Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo


Advertise on this site.